These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11576222)

  • 1. Evidence of the extrathymic development of tyrosinase-related protein-2-recognizing CD8+ T cells with low avidity.
    Harada M; Yamada H; Tatsugami K; Nomoto K
    Immunology; 2001 Sep; 104(1):67-74. PubMed ID: 11576222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of vaccine-induced effector CD8 T cell responses directed against self- and non-self-tumor antigens: implications for cancer immunotherapy.
    Pedersen SR; Sørensen MR; Buus S; Christensen JP; Thomsen AR
    J Immunol; 2013 Oct; 191(7):3955-67. PubMed ID: 24018273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma.
    Steitz J; Brück J; Lenz J; Knop J; Tüting T
    Cancer Res; 2001 Dec; 61(24):8643-6. PubMed ID: 11751377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of anti-self CD8 T-cell responses stimulated by recombinant Listeria monocytogenes expressing the melanoma antigen TRP-2.
    Bruhn KW; Craft N; Nguyen BD; Yip J; Miller JF
    Vaccine; 2005 Jul; 23(33):4263-72. PubMed ID: 15913853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma progression despite infiltration by in vivo-primed TRP-2-specific T cells.
    Singh V; Ji Q; Feigenbaum L; Leighty RM; Hurwitz AA
    J Immunother; 2009; 32(2):129-39. PubMed ID: 19238011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system tumor immunity generated by a recombinant listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden.
    Prins RM; Bruhn KW; Craft N; Lin JW; Kim CH; Odesa SK; Miller JF; Liau LM
    Neurosurgery; 2006 Jan; 58(1):169-78; discussion 169-78. PubMed ID: 16385341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin-fusion degradation pathway plays an indispensable role in naked DNA vaccination with a chimeric gene encoding a syngeneic cytotoxic T lymphocyte epitope of melanocyte and green fluorescent protein.
    Zhang M; Ishii K; Hisaeda H; Murata S; Chiba T; Tanaka K; Li Y; Obata C; Furue M; Himeno K
    Immunology; 2004 Aug; 112(4):567-74. PubMed ID: 15270727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reevaluation of the origin of CD44(high) "memory phenotype" CD8 T cells: comparison between memory CD8 T cells and thymus-independent CD8 T cells.
    Yamada H; Matsuzaki G; Chen Q; Iwamoto Y; Nomoto K
    Eur J Immunol; 2001 Jun; 31(6):1917-26. PubMed ID: 11433389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive selection of extrathymically developed T cells by self-antigens.
    Yamada H; Ninomiya T; Hashimoto A; Tamada K; Takimoto H; Nomoto K
    J Exp Med; 1998 Aug; 188(4):779-84. PubMed ID: 9705960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo.
    Sanchez-Perez L; Kottke T; Diaz RM; Ahmed A; Thompson J; Chong H; Melcher A; Holmen S; Daniels G; Vile RG
    Cancer Res; 2005 Mar; 65(5):2009-17. PubMed ID: 15753401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.
    Niethammer AG; Xiang R; Ruehlmann JM; Lode HN; Dolman CS; Gillies SD; Reisfeld RA
    Cancer Res; 2001 Aug; 61(16):6178-84. PubMed ID: 11507070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
    Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
    J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.
    Prins RM; Odesa SK; Liau LM
    Cancer Res; 2003 Dec; 63(23):8487-91. PubMed ID: 14679014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model.
    Kalat M; Küpcü Z; Schüller S; Zalusky D; Zehetner M; Paster W; Schweighoffer T
    Cancer Res; 2002 Oct; 62(19):5489-94. PubMed ID: 12359758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of phenotypically distinct NK1.1+ T cells upon antigen expression in the thymus or in the liver.
    Legendre V; Boyer C; Guerder S; Arnold B; Hämmerling G; Schmitt-Verhulst AM
    Eur J Immunol; 1999 Jul; 29(7):2330-43. PubMed ID: 10427996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens.
    Wolchok JD; Srinivasan R; Perales MA; Houghton AN; Bowne WB; Blachere NE
    Cancer Immun; 2001 Aug; 1():9. PubMed ID: 12747770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses.
    Sutmuller RP; van Duivenvoorde LM; van Elsas A; Schumacher TN; Wildenberg ME; Allison JP; Toes RE; Offringa R; Melief CJ
    J Exp Med; 2001 Sep; 194(6):823-32. PubMed ID: 11560997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma.
    O I; Blaszczyk-Thurin M; Shen CT; Ertl HC
    Cancer Gene Ther; 2003 Sep; 10(9):678-88. PubMed ID: 12944987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse hepatitis viral infection induces an extrathymic differentiation of the specific intrahepatic alpha beta-TCRintermediate LFA-1high T-cell population.
    Lamontagne L; Massicotte E; Page C
    Immunology; 1997 Mar; 90(3):402-11. PubMed ID: 9155648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients.
    Reynolds SR; Celis E; Sette A; Oratz R; Shapiro RL; Johnston D; Fotino M; Bystryn JC
    J Immunol; 1998 Dec; 161(12):6970-6. PubMed ID: 9862732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.